Mereo BioPharma Group Plc (MREO)
0.3366
+0.01
(+3.16%)
USD |
NASDAQ |
Apr 17, 16:00
0.3296
-0.01
(-2.08%)
After-Hours: 06:58
Mereo BioPharma Group SG&A Expense (Quarterly) : 4.191M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 1.472M |
| Bicycle Therapeutics Plc | 20.86M |
| Autolus Therapeutics Plc | 35.74M |
| AstraZeneca PLC | 152.78M |